CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 76 filers reported holding CUE BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,683 | -37.0% | 4,210 | 0.0% | 0.00% | – |
Q2 2023 | $15,366 | +156.1% | 4,210 | +72.3% | 0.00% | – |
Q2 2022 | $6,000 | -94.8% | 2,443 | -89.8% | 0.00% | – |
Q1 2022 | $116,000 | -57.0% | 23,946 | 0.0% | 0.00% | – |
Q4 2021 | $270,000 | +28.0% | 23,946 | +65.1% | 0.00% | – |
Q3 2021 | $211,000 | +99.1% | 14,507 | +59.0% | 0.00% | – |
Q2 2021 | $106,000 | -7.8% | 9,126 | -3.8% | 0.00% | – |
Q1 2021 | $115,000 | -0.9% | 9,489 | +2.0% | 0.00% | – |
Q4 2020 | $116,000 | -17.1% | 9,299 | 0.0% | 0.00% | – |
Q3 2020 | $140,000 | -45.3% | 9,299 | -10.9% | 0.00% | – |
Q2 2020 | $256,000 | +481.8% | 10,442 | +235.0% | 0.00% | – |
Q1 2020 | $44,000 | -35.3% | 3,117 | -26.9% | 0.00% | – |
Q4 2019 | $68,000 | +126.7% | 4,265 | +20.9% | 0.00% | – |
Q3 2019 | $30,000 | +50.0% | 3,527 | +34.2% | 0.00% | – |
Q2 2019 | $20,000 | 0.0% | 2,628 | 0.0% | 0.00% | – |
Q1 2019 | $20,000 | +66.7% | 2,628 | 0.0% | 0.00% | – |
Q4 2018 | $12,000 | -50.0% | 2,628 | 0.0% | 0.00% | – |
Q3 2018 | $24,000 | -22.6% | 2,628 | 0.0% | 0.00% | – |
Q2 2018 | $31,000 | +40.9% | 2,628 | +68.6% | 0.00% | – |
Q1 2018 | $22,000 | – | 1,559 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,840,510 | $5,245,454 | 2.86% |
P.A.W. CAPITAL CORP | 180,000 | $513,000 | 1.40% |
Bleichroeder LP | 861,278 | $2,454,642 | 0.53% |
Monaco Asset Management SAM | 497,177 | $1,416,954 | 0.43% |
Slate Path Capital LP | 2,402,455 | $6,846,997 | 0.37% |
SILVERARC CAPITAL MANAGEMENT, LLC | 306,278 | $872,892 | 0.25% |
Robertson Stephens Wealth Management, LLC | 478,500 | $1,363,725 | 0.13% |
CARLSON CAPITAL L P | 365,000 | $1,040,250 | 0.08% |
Voss Capital, LLC | 125,000 | $356,250 | 0.07% |
ADVISORY RESEARCH INC | 257,225 | $733,091 | 0.07% |